CORRECTION article

Front. Microbiol., 14 January 2022

Sec. Antimicrobials, Resistance and Chemotherapy

Volume 12 - 2021 | https://doi.org/10.3389/fmicb.2021.821347

Corrigendum: A Systematic Study of the Stability, Safety, and Efficacy of the de novo Designed Antimicrobial Peptide PepD2 and Its Modified Derivatives Against Acinetobacter baumannii

  • 1. Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan

  • 2. Institute of Biochemical Sciences, National Taiwan University, Taipei, Taiwan

  • 3. Department of Biochemical Science and Technology, National Taiwan University, Taipei, Taiwan

Article metrics

View details

2

Citations

1,5k

Views

608

Downloads

In the original article, there was an error. “Gram(–) bacteria” was written where “Gram(+) bacteria” should have been used.

A correction has been made to Results, Antimicrobial Activity is Related to the Lipid Composition of Pathogens, paragraph 1:

“Unlike polymyxins, our peptide could kill Gram(+) bacteria such as Staphylococcus aureus and Staphylococcus epidermidis (Supplementary Figure 2), suggesting that our peptides do not function via LPS binding. When testing other Gram(+) bacteria, we noticed that our peptides were not effective against Enterococcus faecalis at the concentrations used (32 μg/mL and lower). To examine whether the discrimination comes from the bacterial membrane differences, the membrane lipids of these two bacteria were extracted by methanol and chloroform, and TLC was used to analyze the lipid composition (Supplementary Figure 3). The data showed that E. faecalis had much lower contents of phosphatidylethanolamine (PE) and phosphatidylserine (PS) than A. baumannii (Figure 5).”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

antimicrobial peptide, antibiotic-resistant, Acinetobacter baumannii, lipid, membrane, drug-resistant

Citation

Chen S-P, Chen EH-L, Yang S-Y, Kuo P-S, Jan H-M, Yang T-C, Hsieh M-Y, Lee K-T, Lin C-H and Chen RP-Y (2022) Corrigendum: A Systematic Study of the Stability, Safety, and Efficacy of the de novo Designed Antimicrobial Peptide PepD2 and Its Modified Derivatives Against Acinetobacter baumannii. Front. Microbiol. 12:821347. doi: 10.3389/fmicb.2021.821347

Received

24 November 2021

Accepted

27 December 2021

Published

14 January 2022

Volume

12 - 2021

Edited and reviewed by

Rustam Aminov, University of Aberdeen, United Kingdom

Updates

Copyright

*Correspondence: Rita P-Y Chen

This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics